Search hospitals
>
Michigan
>
Kalamazoo
West Michigan Cancer Center
Claim this profile
Kalamazoo, Michigan 49007
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
Conducts research for Breast cancer
572 reported clinical trials
2 medical researchers
Summary
West Michigan Cancer Center is a medical facility located in Kalamazoo, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Ovarian Cancer, Breast cancer and other specialties. West Michigan Cancer Center is involved with conducting 572 clinical trials across 554 conditions. There are 2 research doctors associated with this hospital, such as Kathleen J. Yost and Gitonga Munene, MD.
Area of expertise
Breast Cancer
West Michigan Cancer Center has run 90 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
West Michigan Cancer Center has run 87 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Kathleen J. Yost
Bronson Methodist Hospital
8 years of reported clinical research
Gitonga Munene, MD
West Michigan Cancer Center
2 years of reported clinical research
Clinical Trials running at West Michigan Cancer Center
Lung Cancer
Breast Cancer
Pancreatic Cancer
Breast cancer
Bladder Cancer
Colorectal Cancer
Multiple Myeloma
Ovarian Cancer
Non-Small Cell Lung Cancer
Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting
2 awards
Phase 3
14 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at West Michigan Cancer Center?
West Michigan Cancer Center is a medical facility located in Kalamazoo, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Ovarian Cancer, Breast cancer and other specialties. West Michigan Cancer Center is involved with conducting 572 clinical trials across 554 conditions. There are 2 research doctors associated with this hospital, such as Kathleen J. Yost and Gitonga Munene, MD.
Where is West Michigan Cancer Center located?
The West Michigan Cancer Center is located at 200 N Park St. Kalamazoo, MI 49007, in downtown Kalamazoo. To reach us from South of Kalamazoo, take US-131 north to Business 131 (exit 36A-Stadium Drive), follow Business 131 to M-43 (W. Michigan), turn right onto M-43, continue to North Park, turn left onto North Park, and WMCC will be on your right.
Who should I call to ask about financial aid or insurance network?
**West Michigan Cancer Center Contact Information** **Financial Assistance:** - **Phone:** (616) 954-9800 or (800) 411-7999 - **Website:** Visit for resources and insurance forms. **Insurance and Billing:** - **Phone:** (269) 373-0148 - **Email:** billing@wmcc.org - **Note:** They work with many insurance plans and will bill your insurance. Remaining charges after insurance are the patient's responsibility. **Additional Resources:** - **Medicare:** (800) 633-4227, www.Medicare.gov - **Medicaid:** (855) 275-6424, www.Medicaid.gov - **Veterans Benefits:** (800) 827-1000, www.va.gov/service-member-benefits/ - **Social Security Disability:** (800) 772-1213, www.ssa.gov/applyfordisability/ - **Supplemental Security Income:** (800) 772-1213, www.ssa.gov/benefits/ssi/ **Medical Social Work and Dietitian Services:** - **Medical Social Workers:** (269) 384-8629, socialwork@wmcc.org - **Registered Dietitians:** (269) 373-0109, nutrition@wmcc.org
What insurance does West Michigan Cancer Center accept?
The West Michigan Cancer Center accepts a wide range of insurance plans, including but not limited to Aetna, Blue Cross Blue Shield of Michigan, Cigna-Priority Health Strategic Alliance, Humana Medicare HMO & PPO, McLaren Health Plans, Meridian Medicare, Molina Healthcare, Priority Health, TriCare, United Health Care, and VA/VACCN Optum. For a comprehensive list of accepted insurance plans, it is recommended to contact the center directly. This ensures that your specific insurance plan is accepted.
What awards or recognition has West Michigan Cancer Center received?
The West Michigan Cancer Center, located in Kalamazoo, Michigan, is a recognized National Cancer Institute Community Oncology Research Program (NCORP) site, offering access to advanced clinical cancer trials. It holds accreditations from the American Society of Clinical Oncology (ASCO) and the American College of Radiation Oncology (ACRO), underscoring its dedication to excellence in care and research.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.